InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by De La Rosa Abel, Director. Director active across 1 companies, notably Virios Therapeutics, Inc.. Cumulatively, 2 filings have been published. Total volume traded: €42k. The latest transaction was filed on 7 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€20,8774,000 shares@ €5.2191100.0% of flow
Common Stock
SEC:0001415889-22-000462·
Ideal exit: 4 Oct 2022 (T+270)
€20,8774,000 shares@ €5.219150.0% of flow
Common Stock
SEC:0001415889-22-000462:0·
Ideal exit: 4 Oct 2022 (T+270)
2 of 2 declarations
About De La Rosa Abel
Abel De La Rosa is a Director at Virios Therapeutics, Inc. As a board member, he contributes to the governance of the company and its strategic direction. His experience in the biotechnology field allows him to provide valuable insights into the development of new treatments.
